Source: International Congress 2016 – Molecular targets in pulmonary disease
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Shwu-Fan Ma (Chicago, United States of America), Yong Huang, Shwu-Fan Ma, Rekha Vij, Justin Oldham, Gary Huffnagle, John Erb-Downward, Kevin Flaherty, Beth Moore, Eric White, Tong Zhou, Jianrong Li, Yves Lussier, MeiLan K. Han, Milena Espindola, Joe G.N. Garcia, Cory Hogaboam, Fernando J. Martinez, Imre Noth, For the COMET Investigators. Microbes mediated host innate immune response in idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: Suppl. 60, 881

Member's Comments

No comment yet.

Related content which might interest you: Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis Source: Eur Respir Mon 2011; 52: 11-21 Year: 2011 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Severe lung inflammation is a feature of IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Role of MUC1 in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Role of Wnt-1, Wnt-3 and MMP-7 in fibrotic response in extrinsic allergic alveolitis and idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-? Source: ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017 Year: 2017 Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Role of the inflammasome in idiopathic pulmonary fibrosis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Immune reconstitution inflammatory syndrome associated with pulmonary pathogens Source: Eur Respir Rev 2017; 26: 160042 Year: 2017 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 Immunoproteasome expression in pulmonary fibrosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Distinct clinical and pathological phenotypes in IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013